CRF TrialMax eCOA solution tapped for late-stage oncology study

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/Dragana991)
(Image: Getty/Dragana991)

Related tags: eclinical, Clinical trial, Data management

CRF Health has partnered with an unnamed US biotech for the use of its TrialMax eCOA solution in a Phase III prostate cancer study.

TrialMax – an eClinical outcome assessment (eCOA) solution – will be used in a trial sponsored by an unnamed US Biotech.

The Phase III trial for prostate cancer will involve more than 75 sites in more than 10 countries, with up to 1,000 participants.

Bill Byron, VP of product strategy and innovation at CRF Health, told us, “The driver for the use of TrialMax was to obtain quality data easily. [Patient reported outcome] PRO data collected on paper is often subject to ambiguous, missing and conflicting entries. Using TrialMax to collect these data electronically eliminates these concerns.”

The sponsor partnered with CRF to use the platform to provide support in collecting clinical and endpoint data electronically. The platform was also chosen by the sponsor due to its ability to address PRO measure completion.

Participants in this study have failed all other treatment options and are seriously ill. The platform will allow the patients to conduct questionnaires and comply with the trial regulations in privacy.

“In this study, our solution means that patients can complete the patient reported outcomes measures at their own pace and in privacy, stop and starting as necessary – which is helpful if they are feeling unwell – while maintaining the integrity and completeness of the data collected,”​ Byron said.

CRF Health recently launched a self-service model for eConsent​ called TrialConsent which serves as another eCOA platform that CRF offers. 

Related news

Show more

Related products

show more

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Covance Touchless Drug and Device Vigilance Vision

Covance Touchless Drug and Device Vigilance Vision

Covance Patient Safety | 01-Sep-2020 | Data Sheet

Automation tools enable organizations to identify patterns in structured and unstructured data and facilitate automation of the entire product vigilance...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Related suppliers

Follow us

Products

View more

Webinars